Ajax-Loading

Novartis AG - Change In Other Working Capital

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Change-In-Other-Working-Capital" stands at 0.512 Billion United States Dollars for the trailing twelve months (TTM) period ending 03/31/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.372 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.372 Billion United States Dollars.
The 3 year change is -1.38 Billion United States Dollars.
The 5 year change is -3.25 Billion United States Dollars.

The Serie's long term average value is 1.54 Billion United States Dollars. It's latest available value, on 03/31/2024, is -1.03 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2022, to it's latest available value, on 03/31/2024, is +1.42 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2019, to it's latest available value, on 03/31/2024, is -3.77 Billion.

Change In Other Working Capital for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Change In Other Working Capital905,699,262,464.00
LogoJohnson & Johnson - Change In Other Working Capital486,508,953,600.00
LogoAbbVie Inc - Change In Other Working Capital399,570,305,024.00
LogoRoche Holding AG - Change In Other Working Capital317,433,206,677.55
LogoAstraZeneca PLC - Change In Other Working Capital280,205,508,085.11